Agroaxis creates the first GreenMab® technology platform with plants Snuff “Human “Insulin for obtaining
More on Agroaxis
The biotechnology company Agroaxis, located the Technology Park of Puerto e Santa María, Cádiz (Spain) founded in 2010, is specialised in R&D, production and marketing of biotech drugs produced through GreenMab ® technology platform and the commercialization of nutraceutics products.
The innovative process of the platform allows to significantly reducing production costs while maintaining the highest standards of quality, resulting in a significant reduction of the final sales price.
The production structure of their technology Vertical Greenhouse Pharming ( VPG ® ) formed by vertical structures for crop production using a hydroponics system , integrated into tight spaces with low energy requirements, for the production of recombinant proteins and monoclonal antibodies for obtaining of medications such as insulin , EPO, etc.
Parallel Agroaxis is leading a research project in collaboration with the University of Santiago de Compostela and the University of Cadiz, for the “production of a human protein therapeutic use vegetable biofactories “funded through the Sub INNPACTO 2011, financed European Funds, the Ministry of Economy and Competitiveness. The project is in its third year of implementation and aims to use snuff as biofactory plant for the production of EPO.
The young company has also received support from the Ministry of Science and Innovation through the Support for the recruitment of highly qualified through Subprograma Inncorpora 2010 and Inncorpora FPGS, Inncorpora TU 2011 through the Ministry of Economy and Competitiveness and the granting of Innplanta 2011 for the acquisition of sophisticated equipment for R & D.
For more information contact:
Head of Communication and Marketing: Paula Esteban del Rio
|Copyright 2013 Agroaxis. All Rights Reserved|